All Stories

  1. Acceptance of pharmacist-led stewardship recommendations for patients with community-acquired pneumonia
  2. Meta-analysis of predictors of healthcare-associated Clostridioides difficile infection
  3. Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP)
  4. Diagnostic prediction models to identify patients at risk for healthcare-facility–onset Clostridioides difficile: A systematic review of methodology and reporting
  5. Intravenous to Oral Antibiotic Switch Therapy among Patients Hospitalized with Community-Acquired Pneumonia
  6. Derivation and external validation of a prediction model for pneumococcal urinary antigen test positivity in patients with community-acquired pneumonia
  7. Can Electronic Clinical Decision Support Systems Improve the Diagnosis of Urinary Tract Infections? : A Systematic Review and Meta-Analysis
  8. Adoption and Trends in Uptake of Updated ICD-10 Codes for Clostridioides difficile – A Retrospective Observational Study
  9. Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia
  10. Association of fluoroquinolones or cephalosporin plus macrolide with Clostridioides difficile infection (CDI) after treatment for community-acquired pneumonia
  11. Epidemiology and Outcomes of Community-acquired Escherichia coli Pneumonia
  12. Change in individual physicians’ screening mammography completion rates following the updated USPSTF guideline supporting shared decision making: An observational cohort study
  13. Risk factors for Clostridioides difficile colonization among hospitalized adults: A meta-analysis and systematic review
  14. Monitoring the effectiveness of daily cleaning practices in an intensive care unit (ICU) setting using an adenosine triphosphate (ATP) bioluminescence assay
  15. Early Readmissions after Esophagectomy for Esophageal Adenocarcinoma: Does Facility Case-Volume Matter?
  16. Multidrug-resistant organisms on patients hands in an ICU setting
  17. Acute Ischemic Stroke Therapy in Infective Endocarditis: Case Series and Systematic Review
  18. Risk factors for Clostridium difficile infection in pediatric inpatients: A meta-analysis and systematic review
  19. Hospital readmissions related to Clostridium difficile infection in the United States
  20. Comparative Antimicrobial Efficacy of Two Hand Sanitizers in Intensive Care Units Common Areas: A Randomized, Controlled Trial
  21. Are hospital floors an underappreciated reservoir for transmission of health care-associated pathogens?
  22. Diagnostic testing methods for Clostridium difficile infection: A statewide survey of Ohio acute care hospitals
  23. Rising Incidence of Clostridium difficile Related Discharges among Hospitalized Children in the United States
  24. Accuracy of loop-mediated isothermal amplification for the diagnosis of Clostridium difficile infection: a systematic review
  25. Mo1844 Effect of Fidaxomicin on Susceptibility to Intestinal Colonization With Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice
  26. Statin Therapy and Mortality from Sepsis: A Meta-analysis of Randomized Trials
  27. Colonization Versus Carriage of Clostridium difficile
  28. Sustained increase in resident meal time hand hygiene through an interdisciplinary intervention engaging long-term care facility residents and staff
  29. Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis
  30. Low Incidence of Clostridium difficile Infection (CDI) in Patients Treated with Outpatient Parenteral Antimicrobial Therapy (OPAT)
  31. Clostridium difficile Infection in Hospitalized Patients with Cystic Fibrosis
  32. Evaluation of a Sporicidal Peracetic Acid/Hydrogen Peroxide–Based Daily Disinfectant Cleaner
  33. Metabolomics Analysis Identifies Intestinal Microbiota-Derived Biomarkers of Colonization Resistance in Clindamycin-Treated Mice
  34. Sensitive and Selective Culture Medium for Detection of Environmental Clostridium difficile Isolates without Requirement for Anaerobic Culture Conditions
  35. More Cleaning, Less Screening: Evaluation of the Time Required for Monitoring versus Performing Environmental Cleaning
  36. A Randomized Trial of Soap and Water Hand Wash Versus Alcohol Hand Rub for Removal of Clostridium difficile Spores from Hands of Patients
  37. Pseudo-Outbreak of Klebsiella oxytoca Spontaneous Bacterial Peritonitis Attributed to Contamination of Multidose Vials of Culture Medium Supplement
  38. Efficacy of Dilute Hypochlorite Solutions and an Electrochemically Activated Saline Solution Containing Hypochlorous Acid for Disinfection of Methicillin-Resistant Staphylococcus aureus in a Pig Skin Model
  39. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients
  40. Clostridium difficile Infection in the Hospitalized Pediatric Population
  41. Use of Lactobacillus in Prevention of Recurrences of Clostridium difficile Infection in Solid Organ Transplant Recipients
  42. Evaluation of a commercial real-time polymerase chain reaction assay for detection of environmental contamination with Clostridium difficile
  43. Diagnostic Testing for Clostridium difficile Infection in Patients With Inflammatory Bowel Disease
  44. Vascular endothelial growth factor in the CSF of elderly patients with ventriculomegaly: Variability, periodicity and levels in drainage responders and non-responders
  45. Utility of an Adenosine Triphosphate Bioluminescence Assay to Evaluate Disinfection of Clostridium difficile Isolation Rooms
  46. Outpatient Healthcare Settings and Transmission of Clostridium difficile
  47. Appropriateness of empiric therapy in patients with suspectedClostridium difficileinfection
  48. Clostridium difficile infection in children: a comprehensive review
  49. Deficient Reporting and Interpretation of Non-Inferiority Randomized Clinical Trials in HIV Patients: A Systematic Review
  50. An Environmental Disinfection Odyssey: Evaluation of Sequential Interventions to Improve Disinfection of Clostridium difficile Isolation Rooms
  51. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis
  52. Health Care Burden of Clostridium difficile Infection in Hospitalized Children with Inflammatory Bowel Disease
  53. Potential for Transmission of Spores by Patients Awaiting Laboratory Testing to Confirm Suspected Clostridium difficile Infection
  54. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: A meta-analysis
  55. Reply
  56. Repeat stool testing for Clostridium difficile using enzyme immunoassay in patients with inflammatory bowel disease increases diagnostic yield
  57. Association ofClostridium difficileinfection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database
  58. Valproate-induced hyperammonemic encephalopathy: a brief review
  59. Reply
  60. Increased Rate of Spontaneous Bacterial Peritonitis Among Cirrhotic Patients Receiving Pharmacologic Acid Suppression
  61. Association Between Proton Pump Inhibitor Therapy and Clostridium difficile Infection in a Meta-Analysis
  62. Robotics as a new surgical minimally invasive approach to treatment of endometriosis: a systematic review
  63. Clinical approach to severe Clostridium difficile infection: Update for the hospital practitioner
  64. Diagnostic Accuracy of Real-time Polymerase Chain Reaction in Detection of Clostridium difficile in the Stool Samples of Patients With Suspected Clostridium difficile Infection: A Meta-Analysis
  65. Effect of rural-to-urban within-country migration on cardiovascular risk factors in low- and middle-income countries: a systematic review
  66. Repeat Stool Testing to Diagnose Clostridium difficile Infection Using Enzyme Immunoassay Does Not Increase Diagnostic Yield
  67. Stability Analysis of Vascular Endothelial Growth Factor in Cerebrospinal Fluid
  68. Pulmonary hypertension: An important predictor of outcomes in patients undergoing non-cardiac surgery
  69. Shunting in chronic hydrocephalus induces VEGFR-2 and blood vessel density changes in the caudate nucleus
  70. Potential value of repeat stool testing for Clostridium difficile stool toxin using enzyme immunoassay?
  71. VEGF/VEGFR-2 changes in frontal cortex, choroid plexus, and CSF after chronic obstructive hydrocephalus
  72. Dissociation between Vascular Endothelial Growth Factor Receptor-2 and Blood Vessel Density in the Caudate Nucleus after Chronic Hydrocephalus
  73. Dissociation between Vascular Endothelial Growth Factor Receptor-2 and Blood Vessel Density in the Caudate Nucleus after Chronic Hydrocephalus
  74. Chronic hydrocephalus–induced hypoxia: Increased expression of VEGFR-2+ and blood vessel density in hippocampus
  75. Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence
  76. VEGF-R2+ activation in the caudate: an adaptive angiogenic response to hypoxia in chronic hydrocephalus?
  77. Hydrocephalus-induced ischemia relating to VEGF-R2 and blood vessel density in hippocampus